| MSCI |
Report |
Operating diluted EPS |
IN-LINE |
pred ~$5.01 vs. cons $4.984 |
MEDIUM |
| MSCI |
Report |
Index ABF run rate |
IN-LINE |
pred ~$954M vs. cons $945.3M |
MEDIUM |
| MSCI |
Report |
Recurring net-new subscription sales |
IN-LINE |
pred ~$53.0M vs. cons $52.7M |
LOW |
| MSCI |
Guide |
FY 2026 free cash flow |
LOWER |
guide $1.47B-$1.53B vs. cons $1.575B |
MEDIUM |
| MSCI |
Guide |
Q2 2026 Analytics revenue growth |
UNKNOWN |
guide ~5% vs. cons UNVERIFIED |
LOW |
| MSCI |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
LOW |
| MSCI |
Return |
5-day cumulative residual |
-3.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — no new forward upside |
LOW |